Specifically, DNX-2401 contains a genetic modification in the E1A gene, which is a 24 bp deletion responsible for Rb binding, enabling this adenovirus to replicate selectively in cancer cells with defects in the Rb pathway and decreasing virus replication in normal cells. The gene discussed is RB1; the disease is cancer.